* ImmuLogic Pharmaceutical Corp., Waltham, Mass., named RobertGerety president and CEO, and elected him to the board of directors.Gerety was vice president of pharmaceutical development for BiogenInc. before going to ImmuLogic in September 1993.* Hygeia Pharmaceuticals Inc., San Diego, appointed MichaelMcKnight, a co-inventor of the company's proprietary technology, aspresident and CEO.* Trimeris Inc., Durham, N.C., named Richard Franco as thecompany's president and CEO. Most recently Franco was vicepresident and general manager of Cerenex Pharmaceuticals and GlaxoDermatology, both divisions of Glaxo Inc.* Somatogen Inc., Boulder, Colo., appointed Andre de Bruin as its newpresident and CEO. Most recently he was chairman, president and CEOof Boehringer Mannheim Corp. in Indianapolis.* CELx Corp., Seattle, named Harvey Hoyt as president, CEO anddirector. Most recently Hoyt was CEO and director of MicroProbeCorp. in Bothell, Wash.* GeneMedicine Inc., Houston, promoted Mark Gessler to the positionof vice president, corporate development.* Telios Pharmaceuticals Inc., San Diego, appointed Donald Grimmand elected M. Blake Ingle to its board of directors.* SYNSORB Biotech Inc., Calgary, Alberta, appointed BradleyThompson as president and CEO, and David Rafter as vice president,product development.* IDUN Pharmaceuticals, La Jolla, Calif., named Donald Karanewskydirector of chemistry.* Somatix Therapy Corp., Alameda, Calif., promoted Joseph Rokovichto the position of vice president, regulatory affairs and projectmanagement.* MedImmune Inc., Gaithersburg, Md., appointed Gordon Macklin to anew seat on the company's board of directors.* The Liposome Co. Inc., Princeton, N.J., hired James "Tony" Boyle tothe newly created position of senior vice president, medical andregulatory affairs.* Collagen Corp., Palo Alto, Calif., appointed Michael Levitt to theposition of vice president of operations.* Gensia Inc., San Diego, hired Patrick Walsh as executive vicepresident and chief operating officer of Gensia Laboratories Ltd.Gensia also promoted Rob Hillman to the position of division vicepresident, pharmaceutical & delivery systems development, andStephen Eisold to vice president and general manager, pharmaceuticals,North America.* Xytronyx Inc., San Diego, appointed David Okrongly as vicepresident of research and development.* Alexion Pharmaceuticals Inc., New Haven, Conn., appointedBernadette Alford to the newly created position of vice president,regulatory affairs and project management.* Matrix Pharmaceutical Inc., Menlo Park, Calif., hired MorganStewart as director, biostatistics and data management.
(c) 1997 American Health Consultants. All rights reserved.